Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2022-10-17 00:00:00 ET · period of report 2022-10-17 · accession 0000899243-22-033709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-17 | 2022-10-17 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +59.7K | 561.9K | +12% | +$124.2K |
| DM | 2022-10-17 | 2022-10-17 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $0.00 | -59.7K | 546.6K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-17 | M | A | 32,056 | $2.08 | 534,255 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-17 | M | A | 27,676 | $2.08 | 561,931 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-10-17 | M | D | 32,056 | $0.00 | 14,368 | D | $2.08 · — to 2029-05-22 | 32,056 Common Stock | (F1) The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-10-17 | M | D | 27,676 | $0.00 | 546,604 | D | $2.08 · — to 2029-11-13 | 27,676 Common Stock | (F2) The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of November 14, 2019, subject to the reporting person's continued employment through each vesting date. |